WVEWave Life Sciences Ltd.

$3B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+37.5% YoY

Gross Profit

-$37M-889.1% margin

Operating Income

-$50M-1201.5% margin

Net Income

-$47M-1141.4% margin

EPS (Diluted)

$-1.38

QoQ Revenue Growth

+73.4%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$27M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$239M

Total Liabilities

$210M

Stockholders' Equity

$29M

Cash & Equivalents

$121M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+37.5%
Gross Profit	-$37M	-$37M	+0.2%
Operating Income	-$50M	-$48M	-4.2%
Net Income	-$47M	-$44M	-7.5%

WVE Q1 2020 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena